KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pacific Biosciences Of California (PACB) Return on Sales (2016 - 2025)

Historic Return on Sales for Pacific Biosciences Of California (PACB) over the last 16 years, with Q3 2025 value amounting to 0.99%.

  • Pacific Biosciences Of California's Return on Sales rose 5300.0% to 0.99% in Q3 2025 from the same period last year, while for Sep 2025 it was 3.26%, marking a year-over-year decrease of 9800.0%. This contributed to the annual value of 2.01% for FY2024, which is 4800.0% down from last year.
  • Per Pacific Biosciences Of California's latest filing, its Return on Sales stood at 0.99% for Q3 2025, which was up 5300.0% from 1.05% recorded in Q2 2025.
  • Pacific Biosciences Of California's Return on Sales' 5-year high stood at 0.47% during Q3 2021, with a 5-year trough of 11.47% in Q1 2025.
  • In the last 5 years, Pacific Biosciences Of California's Return on Sales had a median value of 1.52% in 2024 and averaged 2.22%.
  • Within the past 5 years, the most significant YoY rise in Pacific Biosciences Of California's Return on Sales was 37600bps (2025), while the steepest drop was -94500bps (2025).
  • Pacific Biosciences Of California's Return on Sales (Quarter) stood at 1.92% in 2021, then tumbled by -60bps to 3.08% in 2022, then surged by 54bps to 1.41% in 2023, then soared by 104bps to 0.06% in 2024, then plummeted by -1735bps to 0.99% in 2025.
  • Its Return on Sales was 0.99% in Q3 2025, compared to 1.05% in Q2 2025 and 11.47% in Q1 2025.